Abstract
The planned acquisition of Pacific Biosciences by Illumina could signal a big change in the DNA sequencing landscape, and provides the incentive for an update on a field that still has a number of players and could be disrupted by innovative technologies.
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Séquençage d’ADN, la fin d’un quasi-monopole ?;médecine/sciences;2023-05
2. Bébés CRISPR;médecine/sciences;2019-03